Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy

[1]  O. Witte,et al.  Long-term anticonvulsant therapy leads to low bone mineral density--evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[2]  F. Spener,et al.  Conjugated linoleic acids as functional food: an insight into their health benefits , 2009, Nutrition & metabolism.

[3]  Gert B. M. Mensink,et al.  Vitamin D status and health correlates among German adults , 2008, European Journal of Clinical Nutrition.

[4]  C. Mølgaard,et al.  Pakistani immigrant children and adults in Denmark have severely low vitamin D status , 2008, European Journal of Clinical Nutrition.

[5]  D. Papadimitriou,et al.  Thyroid dysfunction associated with increased low-density lipoprotein cholesterol in epileptic children treated with carbamazepine monotherapy: a causal relationship? , 2007, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[6]  P. Vestergaard,et al.  Adverse effects of antiepileptic drugs on bone mineral density in children , 2007, Expert opinion on drug safety.

[7]  H. Bischoff-Ferrari.  The 25-hydroxyvitamin D threshold for better health , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  J. Wark,et al.  Anti-epileptic medication and bone health , 2007, Osteoporosis International.

[9]  V. Stallings,et al.  Vitamin D Status in Children with Intractable Epilepsy, and Impact of the Ketogenic Diet , 2007, Epilepsia.

[10]  A. Attilakos,et al.  Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy , 2006, Epilepsy Research.

[11]  H. Valsamis,et al.  Antiepileptic drugs and bone metabolism , 2006, Nutrition & metabolism.

[12]  M. Holick,et al.  The role of vitamin D for bone health and fracture prevention , 2006, Current osteoporosis reports.

[13]  R. Vieth.  What is the optimal vitamin D status for health? , 2006, Progress in biophysics and molecular biology.

[14]  A. Attilakos,et al.  Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy , 2006, Epilepsy Research.

[15]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[16]  P. Watkins,et al.  Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. , 2006, The Journal of clinical investigation.

[17]  S. Mintzer,et al.  Vitamin D Levels and Bone Turnover in Epilepsy Patients Taking Carbamazepine or Oxcarbazepine , 2006, Epilepsia.

[18]  Y. Matsinos,et al.  Effects of Anticonvulsant Therapy on Vitamin D Status in Children: Prospective Monitoring Study , 2006, Journal of child neurology.

[19]  B. Mark,et al.  Vitamin D and autoimmune disease--implications for practice from the multiple sclerosis literature. , 2006, Journal of the American Dietetic Association.

[20]  M. Topbaş,et al.  Effect of Antiepileptic Drugs on Plasma Lipids, Lipoprotein (a), and Liver Enzymes , 2006, Journal of child neurology.

[21]  A. Ponsonby,et al.  UVR, Vitamin D and Three Autoimmune Diseases—Multiple Sclerosis, Type 1 Diabetes, Rheumatoid Arthritis , 2005, Photochemistry and photobiology.

[22]  Kazutoshi Nakamura,et al.  Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. , 2005, The American journal of clinical nutrition.

[23]  A. Kalueff,et al.  Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice , 2005, Brain Research Bulletin.

[24]  W. Grant,et al.  Benefits and requirements of vitamin D for optimal health: a review. , 2005, Alternative medicine review : a journal of clinical therapeutic.

[25]  V. Matkovic,et al.  Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting fracture risk. , 2005, Clinical therapeutics.

[26]  Pascal G. P. Martin,et al.  Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. , 2005, The Journal of clinical investigation.

[27]  J. Bilezikian,et al.  Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. , 2004, Arquivos de neuro-psiquiatria.

[28]  Ç. Ecevit,et al.  Effect of carbamazepine and valproate on bone mineral density. , 2004, Pediatric neurology.

[29]  G. Mishra,et al.  Effects of usual nutrient intake and vitamin D status on markers of bone turnover in Swiss adolescents , 2004, European Journal of Clinical Nutrition.

[30]  S. Karasalihoǧlu,et al.  Bone mineral metabolism changes in epileptic children receiving valproic acid , 2004, Journal of paediatrics and child health.

[31]  R. Vieth.  Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  L. Fitzpatrick.  Pathophysiology of bone loss in patients receiving anticonvulsant therapy , 2004, Epilepsy & Behavior.

[33]  F. Tylavsky,et al.  Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. , 2003, The American journal of clinical nutrition.

[34]  B. Otlu,et al.  Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid , 2003, Brain and Development.

[35]  J. Viikari,et al.  Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study. , 2002, The American journal of clinical nutrition.

[36]  G. Latini,et al.  Increased Bone Turnover in Prepubertal, Pubertal, and Postpubertal Patients Receiving Carbamazepine , 2002, Epilepsia.

[37]  M. Moustaki,et al.  Alkaline phosphatase and its isoenzyme activity for the evaluation of bone metabolism in children receiving anticonvulsant monotherapy , 2002, Seizure.

[38]  W. Spain,et al.  Antiepileptic drug-induced bone loss in young male patients who have seizures. , 2002, Archives of neurology.

[39]  Shlomo Shinnar,et al.  Update on the Epidemiology and Prognosis of Pediatric Epilepsy , 2002, Journal of child neurology.

[40]  F. Rauch,et al.  Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine. , 2001, Pediatrics.

[41]  K. Nakamura,et al.  Low serum concentrations of 25-hydroxyvitamin D in young adult Japanese women: a cross sectional study. , 2001, Nutrition.

[42]  S. Atkinson,et al.  Long‐Term Valproate and Lamotrigine Treatment May Be a Marker for Reduced Growth and Bone Mass in Children with Epilepsy , 2001, Epilepsia.

[43]  K. Satoh,et al.  Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy [RETRACTED] , 2001, Neurology.

[44]  M. Kärkkäinen,et al.  Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density. , 2001, The American journal of clinical nutrition.

[45]  R. Vieth,et al.  Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. , 2001, The American journal of clinical nutrition.

[46]  M. Castro‐Gago,et al.  The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy , 2000, Epilepsy Research.

[47]  F. Chiarelli,et al.  Increased bone turnover in epileptic patients treated with carbamazepine , 2000, Annals of neurology.

[48]  G Pearce,et al.  Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  T. Erselcan,et al.  Effect of Antiepileptic Drugs on Bone Mineral Density in Children Between Ages 6 and 2 Years , 1999, Clinical pediatrics.

[50]  V. Okutan,et al.  Evaluation of bone mineral density in children receiving antiepileptic drugs. , 1998, Pediatric neurology.

[51]  K. Tsai,et al.  Effect of Exercise and Exogenous Glucocorticoid on Serum Level of Intact Parathyroid Hormone , 1997, International journal of sports medicine.

[52]  O. Doğu,et al.  Serum lipids in epileptic children treated with carbamazepine and valproate , 1997, European Journal of Pediatrics.

[53]  M. T. Baer,et al.  Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status. , 1997, The American journal of clinical nutrition.

[54]  S. Bloomfield,et al.  Bone mass and endocrine adaptations to training in spinal cord injured individuals. , 1996, Bone.

[55]  M. Holick,et al.  McCollum Award Lecture, 1994: vitamin D--new horizons for the 21st century. , 1994, The American journal of clinical nutrition.

[56]  M. Välimäki,et al.  Bone mineral density measured by dual‐energy X‐ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  N. Callaghan,et al.  A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. , 1986, The Quarterly journal of medicine.

[58]  P. Gosling.  Analytical Reviews in Clinical Biochemistry: Calcium Measurement , 1986, Annals of clinical biochemistry.

[59]  D. Lawson,et al.  Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D. , 1983, The Quarterly journal of medicine.

[60]  A. Kaushik,et al.  Altered vitamin-D metabolism due to anticonvulsant drugs in epileptic children. , 1982, Indian pediatrics.

[61]  K. Kruse,et al.  Response of Kidney and Bone to Parathyroid Hormone in Children Receiving Anticonvulsant Drugs , 1982, Neuropediatrics.

[62]  J. Sivenius,et al.  Osteomalacia in institutionalized epileptic patients on long‐term anticonvulsant therapy , 1981, Acta neurologica Scandinavica.

[63]  T. Sato,et al.  Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy. , 1981, Archives of disease in childhood.

[64]  J. Winnacker,et al.  Rickets in children receiving anticonvulsant drugs. Biochemical and hormonal markers. , 1977, American journal of diseases of children.

[65]  J. Haddad,et al.  Serum 25-Hydroxycalciferol Levels and Bone Mass in Children on Chronic Anticonvulsant Therapy , 1975 .

[66]  J. Maxwell,et al.  Altered Calcium Metabolism in Epileptic Children on Anticonvulsants , 1971, British medical journal.

[67]  A. Richens,et al.  Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy , 1970, British medical journal.

[68]  L. Cowan.  The epidemiology of the epilepsies in children. , 2002, Mental retardation and developmental disabilities research reviews.

[69]  R. Lorentzon,et al.  Influence of Heredity and Environment on Bone Density in Adolescent Boys: A Parent–Offspring Study , 1999, Osteoporosis International.

[70]  A. von zur Mühlen,et al.  Pulse amplitude and frequency modulation of parathyroid hormone in primary hyperparathyroidism. , 1994, The Journal of clinical endocrinology and metabolism.

[71]  P. Hauschka,et al.  Phenytoin affects osteocalcin secretion from osteoblastic rat osteosarcoma 17/2.8 cells in culture. , 1990, Bone.

[72]  P. Berlit,et al.  Effect of long-term treatment with antiepileptic drugs on the vitamin status. , 1988, Drug-nutrient interactions.

[73]  B. Köhler,et al.  Rickets in Children Receiving Anticonvulsant Drugs , 1988 .

[74]  B. Lawrence Riggs,et al.  Osteoporosis : etiology, diagnosis, and management , 1988 .

[75]  L. Arab,et al.  B vitamins in epileptics. , 1986, Bibliotheca nutritio et dieta.

[76]  C. Christiansen,et al.  Pathophysiology behind anticonvulsant osteomalacia. , 1983, Acta neurologica Scandinavica. Supplementum.

[77]  P. Berlit,et al.  Vitamin status in patients on chronic anticonvulsant therapy. , 1982, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.